Cargando…
Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018
We evaluated MarketScan, a large commercial insurance claims database, for its potential use as a stable and consistent source of information on Lyme disease diagnoses in the United States. The age, sex, and geographic composition of the enrolled population during 2010–2018 remained proportionally s...
Autores principales: | Schwartz, Amy M., Kugeler, Kiersten J., Nelson, Christina A., Marx, Grace E., Hinckley, Alison F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853566/ https://www.ncbi.nlm.nih.gov/pubmed/33496238 http://dx.doi.org/10.3201/eid2702.202728 |
Ejemplares similares
-
Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010–2018
por: Kugeler, Kiersten J., et al.
Publicado: (2021) -
Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005–2010
por: Nelson, Christina A., et al.
Publicado: (2015) -
Surveillance for Lyme Disease — United States, 2008–2015
por: Schwartz, Amy M., et al.
Publicado: (2017) -
1614. Single-Dose Doxycycline as Lyme Disease Post-Exposure Prophylaxis in a National Commercial Insurance Claims Database―the United States, 2014–2017
por: Marx, Grace E, et al.
Publicado: (2019) -
1428. Lyme Disease Treatment in the United States: Prescribing Patterns from a Nationwide Commercial Insurance Database, 2016-2018
por: Beeson, Amy M, et al.
Publicado: (2020)